Open Access

Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population

  • Authors:
    • Xiuting He
    • Hongqin Xu
    • Xiaomei Wang
    • Jing Wu
    • Junqi Niu
    • Pujun Gao
  • View Affiliations

  • Published online on: July 2, 2019     https://doi.org/10.3892/mmr.2019.10455
  • Pages: 2177-2188
  • Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study examined the relationships between the single nucleotide polymorphisms (SNPs) of three members of the apolipoprotein B mRNA‑editing catalytic polypeptide‑like 3 (A3) gene family, A3A, A3B and A3H, and hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC) in a Han Chinese population. A total of 654 patients were enrolled in the study between January 2012 and July 2016, including 104 patients with chronic HBV infection (CHB), 265 patients with HBV‑related liver cirrhosis and 285 patients with HBV‑related HCC. A total of two A3A SNPs (rs7286317 and rs7290153), three A3B SNPs (rs2267398, rs2267401 and rs2076109), and five A3H SNPs (rs56695217, rs139302, rs139297, rs139316 and rs139292) were genotyped using a MassArray system. Statistical analysis and haplotype estimation were conducted using Haploview and Unphased software. No significant associations were observed between the A3A, A3B and A3H SNPs and the development of CHB and HCC. Haplotype analysis revealed that the mutant haplotypes C‑T‑A, C‑T‑G, T‑G‑G and T‑T‑G from the A3B SNPs rs2267398‑rs2267401‑rs2076109 carried a lower risk of HCC than the reference haplotype. These findings suggested that there was no relationship between A3A, A3B and A3H SNPs and CHB progression or HCC development in the Han Chinese population.

References

1 

Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, et al: Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma. Sci Rep. 8:79582018. View Article : Google Scholar : PubMed/NCBI

2 

Chu CM: Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol. 15 (Suppl):E25–E30. 2000. View Article : Google Scholar : PubMed/NCBI

3 

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Henderson S and Fenton T: APOBEC3 genes: Retroviral restriction factors to cancer drivers. Trends Mol Med. 21:274–284. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Teng B, Burant CF and Davidson NO: Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 260:1816–1819. 1993. View Article : Google Scholar : PubMed/NCBI

6 

Swanton C, McGranahan N, Starrett GJ and Harris RS: APOBEC enzymes: Mutagenic fuel for cancer evolution and heterogeneity. Cancer Discov. 5:704–712. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Doehle BP, Schafer A and Cullen BR: Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. Virology. 339:281–288. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Prasetyo AA, Sariyatun R, Revion o, Sari Y, Hudiyon o, Haryati S, Adnan ZA, Harton o and Kageyama S: The APOBEC3B deletion polymorphism is associated with prevalence of hepatitis B virus, hepatitis C virus, Torque Teno virus, and Toxoplasma gondii co-infection among HIV-infected individuals. J Clin Virol. 70:67–71. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Berger G, Durand S, Fargier G, Nguyen XN, Cordeil S, Bouaziz S, Muriaux D, Darlix JL and Cimarelli A: APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog. 7:e10022212011. View Article : Google Scholar : PubMed/NCBI

10 

Nakaya Y, Stavrou S, Blouch K, Tattersall P and Ross SR: In vivo examination of mouse APOBEC3- and human APOBEC3A- and APOBEC3G-mediated restriction of parvovirus and herpesvirus infection in mouse models. J Virol. 90:8005–8012. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Minkah N, Chavez K, Shah P, Maccarthy T, Chen H, Landau N and Krug LT: Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3. Virology. 454-455:215–226. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Henry M, Guetard D, Suspene R, Rusniok C, Wain-Hobson S and Vartanian JP: Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. PLoS One. 4:e42772009. View Article : Google Scholar : PubMed/NCBI

13 

Warren CJ, Xu T, Guo K, Griffin LM, Westrich JA, Lee D, Lambert PF, Santiago ML and Pyeon D: APOBEC3A functions as a restriction factor of human papillomavirus. J Virol. 89:688–702. 2015. View Article : Google Scholar : PubMed/NCBI

14 

OhAinle M, Kerns JA, Li MM, Malik HS and Emerman M: Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe. 4:249–259. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Gansmo LB, Romundstad P, Hveem K, Vatten L, Nik-Zainal S, Lønning PE and Knappskog S: APOBEC3A/B deletion polymorphism and cancer risk. Carcinogenesis. 39:118–124. 2018. View Article : Google Scholar : PubMed/NCBI

16 

Xuan D, Li G, Cai Q, Deming-Halverson S, Shrubsole MJ, Shu XO, Kelley MC, Zheng W and Long J: APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Carcinogenesis. 34:2240–2243. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Long J, Delahanty RJ, Li G, Gao YT, Lu W, Cai Q, Xiang YB, Li C, Ji BT, Zheng Y, et al: A common deletion in the APOBEC3 genes and breast cancer risk. J Natl Cancer Inst. 105:573–579. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Rezaei M, Hashemi M, Hashemi SM, Mashhadi MA and Taheri M: APOBEC3 deletion is associated with breast cancer risk in a sample of southeast iranian population. Int J Mol Cell Med. 4:103–108. 2015.PubMed/NCBI

19 

Gohler S, Da Silva Filho MI, Johansson R, Enquist-Olsson K, Henriksson R, Hemminki K, Lenner P and Försti A: Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population. J Cancer Res Clin Oncol. 142:273–276. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Marouf C, Gohler S, Filho MI, Hajji O, Hemminki K, Nadifi S and Försti A: Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population. BMC Cancer. 16:1652016. View Article : Google Scholar : PubMed/NCBI

21 

Klonowska K, Kluzniak W, Rusak B, Jakubowska A, Ratajska M, Krawczynska N, Vasilevska D, Czubak K, Wojciechowska M, Cybulski C, et al: The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population. Oncotarget. 8:76357–76374. 2017. View Article : Google Scholar : PubMed/NCBI

22 

Zhu M, Wang Y, Wang C, Shen W, Liu J, Geng L, Cheng Y, Dai J, Jin G, Ma H, et al: The eQTL-missense polymorphisms of APOBEC3H are associated with lung cancer risk in a Han Chinese population. Sci Rep. 5:149692015. View Article : Google Scholar : PubMed/NCBI

23 

He XT, Xu HQ, Wang XM, He XS, Niu JQ and Gao PJ: Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol. 23:232–241. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Pons F, Varela M and Llovet JM: Staging systems in hepatocellular carcinoma. HPB (Oxford). 7:35–41. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D and Burroughs AK: Systematic review: The model for end-stage liver disease-should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther. 22:1079–1089. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Selby LK, Tay RX, Woon WW, Low JK, Bei W, Shelat VG, Pang TC and Junnarkar SP: Validity of the barcelona clinic liver cancer and hong kong liver cancer staging systems for hepatocellular carcinoma in singapore. J Hepatobiliary Pancreat Sci. 24:143–152. 2017. View Article : Google Scholar : PubMed/NCBI

27 

Dohi H, Ishizuka M, Minoshima S and Shimizu N: GeneView: Multi-language human gene mapping library with a graphical user interface. Comput Appl Biosci. 9:459–464. 1993.PubMed/NCBI

28 

Dudbridge F: Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 66:87–98. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Cougot D, Neuveut C and Buendia MA: HBV induced carcinogenesis. J Clin Virol. 34 (Suppl 1):S75–S78. 2005. View Article : Google Scholar : PubMed/NCBI

30 

Forner A, Llovet JM and Bruix J: Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Kock J and Blum HE: Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. J Gen Virol. 89:1184–1191. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Suspene R, Guetard D, Henry M, Sommer P, Wain-Hobson S and Vartanian JP: Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci USA. 102:8321–8326. 2005. View Article : Google Scholar : PubMed/NCBI

33 

Chiu YL and Greene WC: The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol. 26:317–353. 2008. View Article : Google Scholar : PubMed/NCBI

34 

Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, Sprinzl MF, Koppensteiner H, Makowska Z, Volz T, et al: Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science. 343:1221–1228. 2014. View Article : Google Scholar : PubMed/NCBI

35 

Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL, Saksena G, et al: An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet. 45:970–976. 2013. View Article : Google Scholar : PubMed/NCBI

36 

Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Børresen-Dale AL, et al: Signatures of mutational processes in human cancer. Nature. 500:415–421. 2013. View Article : Google Scholar : PubMed/NCBI

37 

Burns MB, Temiz NA and Harris RS: Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet. 45:977–983. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Xu R, Zhang X, Zhang W, Fang Y, Zheng S and Yu XF: Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B × antigen mutants and hepatocellular carcinoma. Hepatology. 46:1810–1820. 2007. View Article : Google Scholar : PubMed/NCBI

39 

Zhang T, Cai J, Chang J, Yu D, Wu C, Yan T, Zhai K, Bi X, Zhao H, Xu J, et al: Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma. Hum Mol Genet. 22:1262–1269. 2013. View Article : Google Scholar : PubMed/NCBI

40 

He X, Li J, Wu J, Zhang M and Gao P: Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review). Mol Med Rep. 12:6405–6414. 2015. View Article : Google Scholar : PubMed/NCBI

41 

Chan K, Roberts SA, Klimczak LJ, Sterling JF, Saini N, Malc EP, Kim J, Kwiatkowski DJ, Fargo DC, Mieczkowski PA, et al: An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat Genet. 47:1067–1072. 2015. View Article : Google Scholar : PubMed/NCBI

42 

Caval V, Suspene R, Shapira M, Vartanian JP and Wain-Hobson S: A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3′UTR enhances chromosomal DNA damage. Nat Commun. 5:51292014. View Article : Google Scholar : PubMed/NCBI

43 

Gerlich WH: Medical virology of hepatitis B: How it began and where we are now. Virol J. 10:2392013. View Article : Google Scholar : PubMed/NCBI

44 

Hyams KC: Risks of chronicity following acute hepatitis B virus infection: A review. Clin Infect Dis. 20:992–1000. 1995. View Article : Google Scholar : PubMed/NCBI

45 

McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP and Maynard JE: Acute hepatitis B virus infection: Relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 151:599–603. 1985. View Article : Google Scholar : PubMed/NCBI

46 

Ott JJ, Stevens GA, Groeger J and Wiersma ST: Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 30:2212–2219. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 20 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
He, X., Xu, H., Wang, X., Wu, J., Niu, J., & Gao, P. (2019). Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population. Molecular Medicine Reports, 20, 2177-2188. https://doi.org/10.3892/mmr.2019.10455
MLA
He, X., Xu, H., Wang, X., Wu, J., Niu, J., Gao, P."Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population". Molecular Medicine Reports 20.3 (2019): 2177-2188.
Chicago
He, X., Xu, H., Wang, X., Wu, J., Niu, J., Gao, P."Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population". Molecular Medicine Reports 20, no. 3 (2019): 2177-2188. https://doi.org/10.3892/mmr.2019.10455